Pacer Advisors Inc. Buys 542 Shares of Avantor, Inc. (NYSE:AVTR)

Pacer Advisors Inc. grew its position in Avantor, Inc. (NYSE:AVTR) by 0.5% during the 4th quarter, Holdings Channel reports. The firm owned 99,825 shares of the company’s stock after purchasing an additional 542 shares during the quarter. Pacer Advisors Inc.’s holdings in Avantor were worth $2,103,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp lifted its holdings in Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after purchasing an additional 8,206,695 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Avantor by 653.0% in the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after acquiring an additional 5,354,678 shares during the last quarter. FMR LLC boosted its holdings in shares of Avantor by 557.2% in the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after acquiring an additional 3,963,912 shares in the last quarter. Janus Henderson Group PLC grew its position in Avantor by 18.2% during the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after acquiring an additional 2,719,615 shares during the last quarter. Finally, Principal Financial Group Inc. increased its holdings in Avantor by 146.5% during the 3rd quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock valued at $67,996,000 after purchasing an additional 1,562,018 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 0.2 %

NYSE AVTR opened at $22.26 on Friday. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00. The stock has a 50-day simple moving average of $21.66 and a 200 day simple moving average of $23.43. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The company has a market capitalization of $15.15 billion, a PE ratio of 48.38, a P/E/G ratio of 3.82 and a beta of 1.28.

Analyst Ratings Changes

A number of equities analysts have commented on AVTR shares. Barclays reduced their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Robert W. Baird lowered their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Raymond James dropped their target price on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a research note on Tuesday, January 21st. Wells Fargo & Company decreased their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Finally, UBS Group reaffirmed a “neutral” rating and set a $25.00 price objective (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.38.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.